Financials data is unavailable for this security.
View more
Year on year China Medical System Holdings Ltd 's revenues fell -12.43% from 9.15bn to 8.01bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.26bn to 2.40bn, a -26.33% decrease.
Gross margin | 74.13% |
---|---|
Net profit margin | 19.56% |
Operating margin | 21.20% |
Return on assets | 7.51% |
---|---|
Return on equity | 8.72% |
Return on investment | 8.53% |
More ▼
Cash flow in CNYView more
In 2023, China Medical System Holdings Ltd did not generate a significant amount of cash. However, the company earned 2.50bn from its operations for a Cash Flow Margin of 31.23%. In addition the company used 442.28m on investing activities and also paid 2.13bn in financing cash flows.
Cash flow per share | 0.714 |
---|---|
Price/Cash flow per share | 10.84 |
Book value per share | 7.13 |
---|---|
Tangible book value per share | 5.42 |
More ▼
Balance sheet in CNYView more
Current ratio | 4.28 |
---|---|
Quick ratio | 3.97 |
Total debt/total equity | 0.0717 |
---|---|
Total debt/total capital | 0.0667 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -27.90% and -26.27%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 4.14% |
---|---|
Div growth rate (5 year) | 5.19% |
Payout ratio (TTM) | 40.00% |
EPS growth(5 years) | 5.64 |
---|---|
EPS (TTM) vs TTM 1 year ago | -58.73 |
More ▼